💉 Mounjaro (Tirzepatide) – Dual-Action Treatment for Type 2 Diabetes & Weight Management
Mounjaro is a prescription injectable medication containing tirzepatide, a dual GIP and GLP-1 receptor agonist. It is used to improve blood sugar control in adults with type 2 diabetes and has shown significant benefits in supporting weight loss.
✅ Indications:
- Approved for:
- Type 2 diabetes in adults
- Weight management (off-label use in some countries, approved in others under different brand names)
- Used as an adjunct to diet and exercise
- Not approved for type 1 diabetes or children
📋 Dosage & Administration:
- Form: Prefilled, single-dose injection pen
- Route: Subcutaneous (abdomen, thigh, or upper arm)
- Frequency: Once weekly
- Starting dose: 2.5 mg once weekly, increased gradually to a maintenance dose of up to 15 mg/week, depending on tolerance and treatment goals
⚠️ Warnings & Side Effects:
- Common: Nausea, vomiting, diarrhea, reduced appetite, fatigue
- Serious: Risk of pancreatitis, gastrointestinal problems, hypoglycemia (especially if combined with other diabetes meds)
- Avoid in patients with a history of medullary thyroid carcinoma (MTC) or MEN 2
- Not recommended during pregnancy or breastfeeding